ThromboVision Completes T-Guide® Clinical Trials; Files With the FDA for Clearance to Market

HOUSTON--(BUSINESS WIRE)--Having completed clinical trials of its ThromboGuide® (T-Guide®) Platelet aggregation system, ThromboVision, Inc., a Houston-based biomedical diagnostics company, has filed a 510(k) application with the Food and Drug Administration for clearance to market the T-Guide.